Total Reports
37
Below-median volume
Cat /
Breed profile · FDA CVM July 2026 extract
Ocicat adverse-event record
Adverse-event filings for Ocicat (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.
- #300 of 510
- by report volume (all breeds)
- 37
- FDA CVM reports on file
- 5.4%
- death-coded share of reports
- 6
- Vomiting - top reaction
How the 37 reports break down
By recorded gender -- every report on file for Ocicat, no filtering.
Annual report volume
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Ocicat ranks #300 of 510 by total reports (37). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
- 93,675
- Retriever - Labrador reports (#1)
- 99.0%
- Atlantic Salmon (Salmo salar) death share (#1)
- #300
- This breed, reports of 510
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Ocicat has 37 reports now versus 34 in that prior snapshot: 3 more (8.8%).
- Report change
- +3
- Death-coded reports
- +0
- Death-coded share
- −0.5 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Ocicat changesDeaths Reported
2
of 37 reports
Death-coded share of reports
5.4%
5.4% death-coded
Avg Age at Report
9.0 yr
4.4 kg avg weight
Death-Coded Outcome Share
Ocicat death-coded reports 5.4%
Cross-breed median
5.4% of 37 ocicat reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 4.4 kg (9.7 lbs)
Top Reported Reactions
Vomiting 6
Behavioural disorder NOS 5
Anorexia 4
Lack of efficacy (ectoparasite) - flea 4
Decreased appetite 4
Most Referenced Drugs
Spinosad 6
Cefovecin 3
Selamectin;Sarolaner 3
Robenacoxib 3
Fluticasone 3
Outcome Breakdown
Ongoing
14 (41.2%)
Recovered/Normal
9 (26.5%)
Outcome Unknown
7 (20.6%)
Recovered with Sequela
2 (5.9%)
Euthanized
1 (2.9%)
Died
1 (2.9%)
Gender Distribution
Female 20 (54.1%)
Male 17 (45.9%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2011 | 1 | |
| 2012 | 4 | |
| 2013 | 1 | |
| 2014 | 6 | |
| 2015 | 3 | |
| 2016 | 3 | |
| 2018 | 1 | |
| 2019 | 1 | |
| 2020 | 3 | |
| 2021 | 3 | |
| 2022 | 1 | |
| 2024 | 4 | |
| 2025 | 3 | |
| 2026 | 3 | |
Ocicat FDA adverse-event insights
Signature read: death-coded share at 5.4% is the standout outcome stamp on Ocicat's FDA row. According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Ocicat sits at #300 of 510 by report volume among all breeds and #39 of 55 among cat breeds, with 37 reports and 2 (5.4%) death-coded. Mean age at report: 9.0 years, average weight 4.4 kg (9.7 lbs).
Top reported signs: Vomiting (6), Behavioural disorder NOS (5), Anorexia (4). Most-referenced drug: Spinosad (6 reports), followed by Cefovecin (3) and Selamectin;Sarolaner (3).
Outcome coding on 34 status-recorded reports is dominated by Ongoing (41.2%). Annual submissions ranged 1-2,026 across 14 years on file.
Cat Breeds With a Similar Report Volume
Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.
Nationwide breeds with similar profiles
Two openFDA-derived peer sets for Ocicat, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Similar average weight
Nearest other-species breeds by reported average weight (4.4 kg here).
What to do with this cat
- Compare Ocicat's report volume and death-coded share against similar-volume breeds nationwide. See similar breeds
- Read how death-coded share differs from a mortality rate before drawing conclusions. Breed-specific risks guide
- Browse every cat breed we track for comparison. All cat breeds
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Frequently Asked Questions
How many FDA adverse event reports involve Ocicat? ▼
There are 37 adverse event reports involving Ocicat in the FDA database, of which 2 were death-coded (5.4% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Ocicat ranks #300 of 510 by report volume among all breeds PlainBreed indexes (#39 of 55 among cat breeds).
Where does Ocicat sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Ocicat is #300 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #39 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Ocicat? ▼
The most commonly reported adverse reactions for Ocicat are Vomiting (6 reports), Behavioural disorder NOS (5 reports), Anorexia (4 reports), Lack of efficacy (ectoparasite) - flea (4 reports), Decreased appetite (4 reports).
What drugs are most frequently associated with Ocicat adverse events? ▼
The drugs most frequently referenced in Ocicat adverse event reports are Spinosad (6 reports), Cefovecin (3 reports), Selamectin;Sarolaner (3 reports), Robenacoxib (3 reports), Fluticasone (3 reports).
What is the average age of Ocicat in adverse event reports? ▼
The average age of Ocicat at the time of adverse event reports is 9.0 years, with an average weight of 4.4 kg (9.7 lbs).
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
openFDA Animal & Veterinary Adverse Events (FDA CVM) for Ocicat (Cat), extract as of July 2026 extract. 37 reports · 2 death-coded (5.4% of reports, not a mortality rate) · #300 of 510 by volume.
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →